Addressing stability challenges of mRNA-LNP therapies by Kerstin Pohl | 0 CommentsIn a recent webinar, available on demand, Jingtao Zhang (PhD), Scientific Director, and Daniel Turner, Scientist at Catalent® Pharma Solutions, presented their approaches to addressing stability challenges of mRNA-based products.
Standard mixture for bare fused silica capillary. by Jose Rodriguez-Martinez | 1 CommentHi, is there a recommended standard mixture to evaluate the performance of CZE runs in a bare fused capillary with UV/Vis detector? Thanks.
Addressing stability challenges of mRNA-LNP therapies by Kerstin Pohl | Biopharma, BioPhase 8800 system, BlogsIn a recent webinar, available on demand, Jingtao Zhang (PhD), Scientific Director, and Daniel Turner, Scientist at Catalent® Pharma Solutions, presented their approaches to addressing stability challenges of mRNA-based products.
Standard mixture for bare fused silica capillary. by Jose Rodriguez-Martinez | Biopharma, CE, Data acquisition, Optimizing Performance, QuestionsHi, is there a recommended standard mixture to evaluate the performance of CZE runs in a bare fused capillary with UV/Vis detector? Thanks.